Clinical audit of current Helicobacter pylori treatment outcomes in Singapore
Introduction: H. pylori eradication reduces the risk of gastric malignancies and peptic ulcer disease. First-line therapies include 14-day PAC (proton pump inhibitor [PPI], amoxicillin, clarithromycin) and PBMT (PPI, bismuth, metronidazole, tetracycline). Second-line therapies include 14-day PBMT an...
Saved in:
Main Authors: | Tiing Leong Ang, Kim Wei Lim, Daphne Ang, Yu Jun Wong, Malcolm Tan, Andrew Siang Yih Wong |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer – Medknow Publications
2022-09-01
|
Series: | Singapore Medical Journal |
Subjects: | |
Online Access: | https://journals.lww.com/10.11622/smedj.2021105 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Selecting first-line immunotherapy in advanced melanoma: Current evidence on efficacy across diverse patient populations
by: Sophia Kreft, et al.
Published: (2025-01-01) -
Short-term endoscopic alterations of early gastric cancer after successful eradication of Helicobacter pylori
by: Xiaohan Yan, et al.
Published: (2025-02-01) -
The Main Statements of the Consensus “Maastricht-VI” (2022) on the Diagnostics and Treatment of <i>Helicobacter pylori</i> Infection
by: A. A. Sheptulin
Published: (2023-02-01) -
Clinical efficacy and safety of first‐line nilotinib or imatinib therapy in patients with chronic myeloid leukemia—Nationwide real life data
by: Petra Belohlavkova, et al.
Published: (2024-09-01) -
Prevalence of CagA-positive Helicobacter pylori strain and H. pylori-associated gastritis activity in Tuva schoolchildren of different age groups
by: Tamara V. Polivanova, et al.
Published: (2018-08-01)